Tela Bio
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $19,059 | $20,869 | $20,689 | $20,197 |
Gross Profit | 12,520 | 13,755 | 13,969 | 14,105 |
EBITDA | -10,526 | -6,648 | -7,154 | -8,432 |
EBIT | -7,402 | -8,702 | ||
Net Income | -12,273 | -9,041 | -8,603 | -9,923 |
Net Change In Cash | 19,059 | 20,869 | 20,689 | 20,197 |
Free Cash Flow | -11,289 | -4,961 | -5,930 | -8,019 |
Cash | 39,541 | 50,845 | 29,713 | 34,977 |
Basic Shares | 57,256 | 51,683 | 45,421 | 45,365 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $80,275 | $69,300 | $58,453 | $41,418 |
Gross Profit | 54,341 | 46,488 | 40,112 | 27,044 |
EBITDA | -33,755 | -31,683 | -40,633 | -39,058 |
EBIT | -32,695 | -41,441 | -40,245 | |
Net Income | -38,831 | -37,841 | -46,664 | -44,296 |
Net Change In Cash | 80,275 | 69,300 | 58,453 | 41,418 |
Cost of Revenue | -1,768 | |||
Free Cash Flow | -28,667 | -42,584 | -41,468 | -42,620 |
Cash | 50,845 | 52,670 | 46,729 | 42,019 |
Basic Shares | 46,947 | 28,526 | 22,868 | 16,267 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.21 |
2025-12-31 | -$0.17 |
2025-09-30 | -$0.19 |
2025-06-30 | -$0.22 |